Telecommunication Technology-based Online Survey

Recruiting

• Conditions: Risk Factors; Polypharmacy; Drug Interactions; Self Medication; COVID-19

• Registration Number: NCT06159699
• Lead Sponsor: Tomsk National Research Medical Center of the Russian Academy of Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-11-28
• Last Update Posted: 2 September 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 2000

Inclusion Criteria

Inclusion Criteria:<br><br> - age of 18 years and older<br><br> - signing the informed concent form online<br><br> - completion of the entire questionnaire<br><br>Exclusion Criteria:<br><br> - age under 18 years<br><br> - refuse to sign the informed concent form

Exclusion Criteria

Not provided

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Incidence of serious drug-drug interactions (percent);Median number of serious drug-drug interactions (n)

Secondary Outcome Measures

Name	Time	Method
Incidence of polypharmacy (percent);Incidence of MRI administration (percent);Incidence of CT administration (percent);Incidence of diagnostic ultrasound administration (percent);Incidence of diagnostic X-ray administration (percent);Incidence of scintigraphy administration (percent);Incidence of chest fluoroscopy administration (percent);Clinically significant CYP2D6 gene polymorphisms;Clinically significant ACE gene polymorphisms;Clinically significant UGT1A1 gene polymorphisms;Clinically significant CYP2C9 gene polymorphisms;Clinically significant CYP2C19 gene polymorphisms